SM, L., JN, E., J, M., AJ, W., BA, R., N, C., . . . G, J. (2022). Cumulative Mycobacterium tuberculosis Infection Incidence (Measured Primarily by Tuberculin Skin Test) Among Infants With Human Immunodeficiency Virus Exposure: Observational Follow-up of an Isoniazid Prophylaxis Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75(12), 2253. https://doi.org/10.1093/cid/ciac393
Chicago Style (17th ed.) CitationSM, LaCourse, et al. "Cumulative Mycobacterium Tuberculosis Infection Incidence (Measured Primarily by Tuberculin Skin Test) Among Infants With Human Immunodeficiency Virus Exposure: Observational Follow-up of an Isoniazid Prophylaxis Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 75, no. 12 (2022): 2253. https://doi.org/10.1093/cid/ciac393.
MLA (9th ed.) CitationSM, LaCourse, et al. "Cumulative Mycobacterium Tuberculosis Infection Incidence (Measured Primarily by Tuberculin Skin Test) Among Infants With Human Immunodeficiency Virus Exposure: Observational Follow-up of an Isoniazid Prophylaxis Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 75, no. 12, 2022, p. 2253, https://doi.org/10.1093/cid/ciac393.
